U.S. Medical Debt High, but Varies Geographically
Debt higher in the South, in lowest income ZIP codes, and in states without Medicaid expansion (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 30, 2021 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology, Pediatrics Source Type: news

Report Questions Benefit of FDA Accelerated Approval Pathway
112 of the 253 authorized drugs have not been confirmed as clinically effective; 24 of these have been on market more than five years (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 30, 2021 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pediatric Source Type: news

FDA accepts application for Roche ’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial growt...
Source: Roche Investor Update - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial growt...
Source: Roche Media News - July 29, 2021 Category: Pharmaceuticals Source Type: news

An unusual pure periorbital electrical injury: a case report - Motazedian G, Khojasteh A.
Pure periorbital electrical injuries are uncommonly reported and may cause both immediate and delayed complications. These injuries are rare and pose a difficult challenge for both ophthalmologist and plastic surgeon. Here we report an unusual case of pure... (Source: SafetyLit)
Source: SafetyLit - July 28, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Golden Rice: Triumph for Science
By Paul TengSINGAPORE, Jul 28 2021 (IPS) After almost two decades, Golden Rice was approved last week by the Philippines authorities for use as food. This together with the approval of the bioengineered Bt eggplant represents a landmark victory of science over misinformation; it will provide consumers with improved nutrition (Golden Rice) and safer food (Bt eggplant). Paul TengBIOTECHNOLOGY CROPS have been controversial in spite of overwhelming support for their safety by the scientific community. This is specially so for the class of biotechnology crops commonly called ‘GMO’ or genetically modified organism. ...
Source: IPS Inter Press Service - Health - July 28, 2021 Category: International Medicine & Public Health Authors: Paul Teng Tags: Asia-Pacific Biodiversity Climate Change Economy & Trade Environment Food & Agriculture Food Security and Nutrition Headlines Health TerraViva United Nations Source Type: news

What Is Jaw Wink Ptosis?
Title: What Is Jaw Wink Ptosis?Category: Diseases and ConditionsCreated: 7/27/2021 12:00:00 AMLast Editorial Review: 7/27/2021 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 27, 2021 Category: Opthalmology Source Type: news

UCLA Health hospitals rank No. 1 in L.A. and state, No. 3 in nation
UCLA Health hospitals  are No. 1 in both Los Angeles and California and rose to No. 3 nationally in an annual evaluation published today by U.S. News& World Report. It is the first time UCLA Health has been ranked so highly nationally while also holding the top positions in both the city and the state.UCLA Health once again earned a coveted spot on thenational honor roll, which names only the 20 hospitals that provide the highest-quality care across a wide range of procedures and conditions.UCLA Health earnedtop 10 rankings in 12 specialties: diabetes and endocrinology (3), gastroenterology/gastrointestinal s...
Source: UCLA Newsroom: Health Sciences - July 27, 2021 Category: Universities & Medical Training Source Type: news

An eye on gender equality: a review of the evolving role and representation of women in ophthalmology - Gill H, Niederer RL, Shriver E, Gordon LK, Coleman AL, Danesh-Meyer HV.
PURPOSE: In recent decades, women have achieved greater representation in ophthalmology. Globally, women now constitute about 25-30% of ophthalmologists, and 35-45% of trainees. Nevertheless, women remain under-represented in key areas, including positions... (Source: SafetyLit)
Source: SafetyLit - July 25, 2021 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices
Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 24, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Internal Medicine, Allergy, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Psychiatry, Pulmonology, Radiology, Rheumatology, Source Type: news

Johnson and Johnson Vision Introduces VERITAS Vision System With Features To Address Key Unmet Needs In Cataract Surgery
High-performance, next-generation cataract surgery system is now globally available and offers surgeons enhanced safety and exceptional efficiency SANTA ANA, Calif., July 23, 2021 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision,* ... Devices, Ophthalmology, Product Launch Johnson & Johnson Vision, VERITAS Vision System, phacoemulsification, cataract (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 23, 2021 Category: Pharmaceuticals Source Type: news

Reverse optogenetic tool developed
(Ruhr-University Bochum) A new optogenetic tool, a protein that can be controlled by light, has been characterized by researchers at Ruhr-Universit ä t Bochum. They used an opsin - a protein that occurs in the brain and eyes - from zebrafish and introduced it into the brain of mice. Unlike other optogenetic tools, this opsin is not switched on but rather switched off by light. Experiments also showed that the tool could be suitable for investigating changes in the brain that are responsible for the development of epilepsy. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 23, 2021 Category: Biology Source Type: news

Working safely during COVID-19 - community pharmacy and optometrists
A new update has been published to the guidance relating to those providing services in retail spaces and those providing close contact services. (Source: NHS Networks)
Source: NHS Networks - July 23, 2021 Category: UK Health Source Type: news

Polygenic-Variant Testing Can Help Improves Glaucoma-Risk Prediction Polygenic-Variant Testing Can Help Improves Glaucoma-Risk Prediction
Polygenic risk scores can improve risk stratification in people at increased odds of developing open-angle glaucoma, according to researchers in Australia.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 22, 2021 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

New device could help visually impaired avoid obstacles, research suggests
Chest-mounted video camera and vibrating wristbands developed by US team reduce collisions by 37% in small studyVibrating wristbands could help visually impaired people to avoid collisions when out and about, a study indicates.According to the NHS, about 360,000 people in the UK alone are registered as blind or partially sighted, with long canes and guide dogs among the methods used to help individuals avoid obstacles.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 22, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Blindness and visual impairment Disability Technology Science Source Type: news

Study: Wearable camera reduces collision risk in blind, visually impaired
A wearable computer vision device may help reduce collisions and other accidents in the blind and visually impaired, a study published Thursday by JAMA Ophthalmology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 22, 2021 Category: Consumer Health News Source Type: news

Easement of COVID-19 Restrictions - Delivering Safe Eye Care, College of Optometrists (published 19th July 2021)
The Association of British Dispensing Opticians and The College of Optometrists advise the profession in all nations that you should continue to follow the College's Amber guidance, your national eye care standard operating procedures and the GOC supporting statements for the amber phase. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 22, 2021 Category: Consumer Health News Source Type: news

Generation and application of the high-Q resonance in all-dielectric metasurfaces
(Compuscript Ltd) In a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2021.200030 , Researchers led by Professor Liu Yan from Xidian University, China and Professor Gan Xuetao from Northwestern Polytechnical University, China consider generation and application of the high-Q resonance in all-dielectric metasurfaces. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

The College of Optometrists issue summer eye health tips
The College of Optometrists has issued tips to remind the public that eyes need to be protected, even if you are not travelling to a hotter country. (Source: NHS Networks)
Source: NHS Networks - July 22, 2021 Category: UK Health Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Investor Update - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Media News - July 21, 2021 Category: Pharmaceuticals Source Type: news

Expert shares six indications that dry eye could lead to 'concerning eye problems'
OPTOMETRIST Francesca Marchetti spoke exclusively to Express.co.uk about the long-term dangers of dry eyes. If you find yourself suffering from sore, watery, and red eyes on a frequent basis, your eye health could be at risk. (Source: Daily Express - Health)
Source: Daily Express - Health - July 17, 2021 Category: Consumer Health News Source Type: news

A Better Test to Help Spot Glaucoma?
Title: A Better Test to Help Spot Glaucoma?Category: Health NewsCreated: 7/16/2021 12:00:00 AMLast Editorial Review: 7/16/2021 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 16, 2021 Category: Opthalmology Source Type: news

How Do You Treat Dry Eyes?
Title: How Do You Treat Dry Eyes?Category: Diseases and ConditionsCreated: 7/16/2021 12:00:00 AMLast Editorial Review: 7/16/2021 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 16, 2021 Category: Opthalmology Source Type: news

Study: New genetic test effective at spotting people at high risk for glaucoma
A new genetic test for glaucoma is 15 times more accurate at identifying people at high risk for the eye disease than existing diagnostics, a study published Thursday by JAMA Ophthalmology found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 15, 2021 Category: Consumer Health News Source Type: news

UAB Eye Care begins telemedicine option for optometry services
UAB Eye Care has started using a telemedicine option for optometry services. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 15, 2021 Category: Biotechnology Authors: Tyler Patchen Source Type: news

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
World-leading surgeons to join iSTAR Medical's STAR-V study WAVRE, Belgium, July 15, 2021 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today... Devices, Ophthalmology, FDA iSTAR Medical, micro-invasive glaucoma surgery, MINIject , glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2021 Category: Pharmaceuticals Source Type: news

Edge Pharma Announces New Agreement with Cardinal Health ’s Acuity™ GPO
Edge Pharma, a 503B Outsourcing Facility, has entered into an agreement with Cardinal Health’s Acuity™ GPO to provide its member ophthalmology practices with Edge’s unit-dose MVASI™ (Bevacizumab-awwb)...(PRWeb July 14, 2021)Read the full story at https://www.prweb.com/releases/edge_pharma_announces_new_agreement_with_cardinal_healths_acuity_gpo/prweb18065310.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 14, 2021 Category: Pharmaceuticals Source Type: news

How a tube the width of a hair saved Michael Rosen's eyesight
Former Children's Laureate Michael Rosen spent 40 days in an induced coma last year after developing Covid - and when he finally woke up last May, he was a much-changed man. (Source: the Mail online | Health)
Source: the Mail online | Health - July 12, 2021 Category: Consumer Health News Source Type: news

BioBonds Use Wall Street Tools to Fund Medical Research
Karen Petrou invented a new funding model for curing blindness. Proposed legislation aims to apply it to medical research more generally. (Source: NYT Health)
Source: NYT Health - July 12, 2021 Category: Consumer Health News Authors: Ephrat Livni Tags: Clinical Trials Drugs (Pharmaceuticals) Law and Legislation Petrou, Karen Shaw Research Lobbying and Lobbyists Health and Human Services Department Rush, Bobby L Fitzpatrick, Brian K (1973- ) Source Type: news

You Have a Sixth Sense You Probably Aren't Using Yet You Have a Sixth Sense You Probably Aren't Using Yet
Dolphins do it underwater and bats tap into this in darkness to find their way. Some people who are blind already use it and scientists say it is only a matter of time before more people learn how.WebMD Health News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - July 9, 2021 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Are you overusing hand sanitizer? Doctors say this could lead to blindness and even death
(Natural News) Medical experts are urging caution and telling Americans not to overuse hand sanitizer, especially if it was not manufactured in the United States. This is because the hand sanitizer might contain one toxic chemical: methanol. Hand sanitizers in the U.S. are banned from using methanol. The Food and Drug Administration (FDA) noted that it is... (Source: NaturalNews.com)
Source: NaturalNews.com - July 8, 2021 Category: Consumer Health News Source Type: news

Outrage Over Aetna's Cataract Preapproval Rule Outrage Over Aetna's Cataract Preapproval Rule
Aetna's new preauthorization program for cataract surgeries is causing delays and confusion, according to the American Academy of Ophthalmology.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 8, 2021 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Do Anti-VEGF Injections for Diabetic Retinopathy Impact Mortality? Do Anti-VEGF Injections for Diabetic Retinopathy Impact Mortality?
A signal for higher mortality in patients with diabetic retinopathy using anti-VEGF inhibitors was seen in a new study, but this needs to be looked at more rigorously, says an expert.Medscape Medical News (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - July 8, 2021 Category: Opthalmology Tags: Diabetes & Endocrinology News Source Type: news

Artificial intelligence provides faster diagnosis for debilitating blistering disease
(University of Groningen) Scientists at the University of Groningen have trained an Artificial Intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita. The pattern is characteristic of a specific variant of the disease which can cause scarring of the skin and mucous membranes, and may lead to blindness. The new system is easy to use and is better than most doctors in making the diagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2021 Category: International Medicine & Public Health Source Type: news

What Are the Types of Eye Care?
Title: What Are the Types of Eye Care?Category: Diseases and ConditionsCreated: 9/24/1999 12:00:00 AMLast Editorial Review: 7/7/2021 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - July 7, 2021 Category: Opthalmology Source Type: news

Hand sanitizer will remain in US households post-pandemic but doctors warn overuse can be dangerous
Experts fear that overuse of hand sanitizer, specifically those that use methanol, can be dangerous over time. Methanol, which is banned in the U.S., can cause blindness or death. (Source: the Mail online | Health)
Source: the Mail online | Health - July 7, 2021 Category: Consumer Health News Source Type: news

Assessing knowledge and practice about eye injuries first aid, with awareness about the importance of early management among general population in Asser Region, 2020 - Dhabaan WA, Almutairi KH, Alzahrani AA, Almutlaq AH, Jali Asiri AAH, Hasan Alshahrani RS, Hadi Jali MA, Alqahtani AMA.
BACKGROUND: Eye injury is a leading cause of monocular blindness and is second only to cataract as the commonest cause of visual impairment. Injury is the commonest reason for eye-related emergency department visits. AIM: To assess population aware... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Pharmacological Strategies for Treating Presbyopia Pharmacological Strategies for Treating Presbyopia
Presbyopia is commonly treated with glasses or contact lenses, but novel pharmacologic treatment options are on the horizon.Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

What Problems are Ciliopathies Associated With?
Discussion Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below. The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland. There are 3 subtypes: Infantile Occurs usually within 1 year of life Enlarged kidneys and severe hypertension In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Biden Administration Pushes Forward With Law on Surprise Medical Bills
Proposed provisions would more clearly outline charges to be expected during medical emergencies, offer protections to consumers (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 3, 2021 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Francesca Pignoni, PhD, named Chair of Department of Neuroscience and Physiology
Dr. Pignoni joined Upstate in 2009 as an Empire Scholar in the Department of Ophthalmology. She has played leadership roles in the research and academic efforts of the Ophthalmology department and the Center for Vision Research (CVR). She has served as interim chair of the department since December 2018. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - July 1, 2021 Category: Universities & Medical Training Tags: News Source Type: news

Ask the expert – Primary eye care contracts
These one hour ask the expert sessions are for commissioning teams to discuss any contracting matters they have regarding general ophthalmic services (GOS) contracts. (Source: NHS Networks)
Source: NHS Networks - June 30, 2021 Category: UK Health Source Type: news

FDA Approves Verkazia for Vernal Keratoconjunctivitis FDA Approves Verkazia for Vernal Keratoconjunctivitis
Ophthalmologists now have another option to treat both adults and children with vernal keratoconjunctivitis.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2021 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Risk of Postinjection Endophthalmitis No Higher With Universal Masking Risk of Postinjection Endophthalmitis No Higher With Universal Masking
The risk of developing endophthalmitis after intravitreal injection of anti-VEGF is not increased when healthcare workers and patients wear face masks, according to a large retrospective study.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - June 28, 2021 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Astigmatism Management in Cataract Surgery Astigmatism Management in Cataract Surgery
Dr Sumit (Sam) Garg discusses the effect of anterior capsule overlap on the rotational stability of a toric IOL.Medscape Ophthalmology (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - June 28, 2021 Category: Opthalmology Tags: Ophthalmology Viewpoint Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Media News - June 28, 2021 Category: Pharmaceuticals Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Investor Update - June 28, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Verkazia (cyclosporine ophthalmic emulsion) for the Treatment of Vernal Keratoconjunctivitis
EMERYVILLE, Calif.--(BUSINESS WIRE) June 24, 2021 --Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on eye care, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 24, 2021 Category: Drugs & Pharmacology Source Type: news

FDA accepts application for Roche ’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)
Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Neovascular AMD is a leading cause of blindness for people aged 60 and over and impacts approximatel y 20 million people worldwide.1,2,3 If approved, PDS would be a first-of-its-kind therapeutic approach, offering people living with nAMD an alternative to frequent eye i...
Source: Roche Media News - June 24, 2021 Category: Pharmaceuticals Source Type: news